GLP-1s: What Every Clinician & Patient Should Know with Dr. Amy Givler - Faith in Healthcare: The CMDA Matters Podcast | Lyssna här

Dr. Amy Givler returns to join host Dr. Mike Chupp for the first of two episodes exploring one of the most talked-about drug classes in medicine today: GLP-1 receptor agonists. A family physician who has served patients in northeast Louisiana for decades, Dr. Givler brings both clinical depth and transparency to a conversation happening in primary care offices across the country every single day. They cover how these medications work, who they’re for, what side effects look like, what happens when patients stop taking them, and the honest questions medicine still can’t fully answer.

Chapters

(00:00:08) - CMDA Matters: End of the Year Appeal
(00:02:44) - GLP1s
(00:04:10) - Faith and Healthcare
(00:05:42) - GLP1s and their role in diabetes care
(00:10:07) - GLP1 agonists
(00:13:25) - Gastric acid shots
(00:15:41) - Diabetes care for obese people
(00:20:46) - ICMDA World Congress Announcement
(00:22:40) - Obesity drugs and insurance coverage
(00:27:14) - GLP1 and weight loss
(00:33:23) - Osteoporosis and muscle wasting
(00:36:12) - GLP1 Management
(00:41:14) - Faith in Healthcare: GLP1s

Rss Apple Podcaster